TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/11/2025
Back to search
Official data from USPTO
REGULUS THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REGULUS THERAPEUTICS
ST13
US500000090065302Class
5
Filing
90065302
Registration
7327777
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
09/17/2025
Trademark type
Word
Nice classes
5
Filing date
07/21/2020
Registration date
03/12/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/12/2024
Last transaction
09/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/07/2023
First use in commerce
12/07/2023
Drawing code
4
Owner type
03
Owner location
San Diego, CA
Examiner
EULIN, INGRID
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
REGULUS THERAPEUTICS INC.
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
oligonucleotide preparations for therapeutic pharmaceutical purposes for a wide variety of conditions
Publications
History of USPTO decisions and trademark events.
47 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/02/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/01/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/11/2024
IUAF
USE AMENDMENT FILED
01/05/2024
EISU
TEAS STATEMENT OF USE RECEIVED
01/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/11/2023
EX5G
SOU EXTENSION 5 GRANTED
07/10/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/10/2023
EXT5
SOU EXTENSION 5 FILED
06/29/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/29/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/06/2023
EX4G
SOU EXTENSION 4 GRANTED
01/04/2023
EXT4
SOU EXTENSION 4 FILED
01/04/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/04/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/28/2022
EX3G
SOU EXTENSION 3 GRANTED
06/24/2022
EXT3
SOU EXTENSION 3 FILED
06/24/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/24/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/21/2022
EX2G
SOU EXTENSION 2 GRANTED
01/19/2022
EXT2
SOU EXTENSION 2 FILED
01/19/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/19/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/11/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/11/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/11/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/22/2021
EX1G
SOU EXTENSION 1 GRANTED
07/20/2021
EXT1
SOU EXTENSION 1 FILED
07/20/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/20/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/26/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/01/2020
PUBO
PUBLISHED FOR OPPOSITION
12/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/11/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/23/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
10/22/2020
ALIE
ASSIGNED TO LIE
10/22/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/22/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
10/22/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/22/2020
DOCK
ASSIGNED TO EXAMINER
10/21/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/19/2020
NWAP
NEW APPLICATION ENTERED
07/24/2020
Continuous trademark protection
Get notified about every new filing that threatens REGULUS THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.